1,4-naphthoquinone has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayama, N; Kimachi, T; Murota, H; Nishiuchi, A; Ogata, T; Sakanaka, M; Shinya, T; Takahashi, S; Toda, KI | 1 |
| Kayashima, T; Matsubara, K; Mizushina, Y; Mori, M; Yoshida, H | 1 |
2 other study(ies) available for 1,4-naphthoquinone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Inhibition of angiogenesis and tumor growth by a novel 1,4-naphthoquinone derivative.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Endothelial Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Naphthoquinones; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
1,4-Naphthoquinone is a potent inhibitor of human cancer cell growth and angiogenesis.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Chemotaxis; Colonic Neoplasms; Endothelium, Vascular; Femoral Artery; HeLa Cells; Humans; Male; Naphthoquinones; Neovascularization, Pathologic; Rats; Rats, Wistar; Umbilical Veins | 2009 |